nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—CACNA2D2—neck—head and neck cancer	0.00645	0.119	CbGeAlD
Gabapentin—CACNA1B—connective tissue—head and neck cancer	0.00642	0.119	CbGeAlD
Gabapentin—BCAT1—trachea—head and neck cancer	0.00424	0.0784	CbGeAlD
Gabapentin—CACNA1B—head—head and neck cancer	0.00378	0.07	CbGeAlD
Gabapentin—ADORA1—saliva-secreting gland—head and neck cancer	0.00349	0.0647	CbGeAlD
Gabapentin—BCAT1—thyroid gland—head and neck cancer	0.00335	0.062	CbGeAlD
Gabapentin—CACNA2D2—thyroid gland—head and neck cancer	0.00307	0.0569	CbGeAlD
Gabapentin—BCAT1—head—head and neck cancer	0.00297	0.055	CbGeAlD
Gabapentin—CACNA2D2—head—head and neck cancer	0.00273	0.0505	CbGeAlD
Gabapentin—CACNA1B—lymph node—head and neck cancer	0.00265	0.049	CbGeAlD
Gabapentin—Osteoarthritis—Fluorouracil—head and neck cancer	0.0026	0.00275	CcSEcCtD
Gabapentin—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00258	0.00273	CcSEcCtD
Gabapentin—Pulmonary embolism—Docetaxel—head and neck cancer	0.00258	0.00273	CcSEcCtD
Gabapentin—Blood pressure increased—Docetaxel—head and neck cancer	0.00258	0.00273	CcSEcCtD
Gabapentin—Haemorrhage—Hydroxyurea—head and neck cancer	0.0025	0.00264	CcSEcCtD
Gabapentin—Hallucination—Hydroxyurea—head and neck cancer	0.00248	0.00263	CcSEcCtD
Gabapentin—Colitis—Docetaxel—head and neck cancer	0.00248	0.00262	CcSEcCtD
Gabapentin—Irritability—Fluorouracil—head and neck cancer	0.00248	0.00262	CcSEcCtD
Gabapentin—Cardiac arrest—Fluorouracil—head and neck cancer	0.00247	0.00261	CcSEcCtD
Gabapentin—Skin exfoliation—Docetaxel—head and neck cancer	0.00247	0.00261	CcSEcCtD
Gabapentin—Candida infection—Docetaxel—head and neck cancer	0.00247	0.00261	CcSEcCtD
Gabapentin—Fluid retention—Docetaxel—head and neck cancer	0.00245	0.00259	CcSEcCtD
Gabapentin—Ataxia—Fluorouracil—head and neck cancer	0.00244	0.00258	CcSEcCtD
Gabapentin—Neuropathy—Docetaxel—head and neck cancer	0.00242	0.00256	CcSEcCtD
Gabapentin—Alopecia—Vinblastine—head and neck cancer	0.00242	0.00256	CcSEcCtD
Gabapentin—Dry skin—Fluorouracil—head and neck cancer	0.00238	0.00252	CcSEcCtD
Gabapentin—Oesophagitis—Docetaxel—head and neck cancer	0.00236	0.00249	CcSEcCtD
Gabapentin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00232	0.00246	CcSEcCtD
Gabapentin—Pulmonary oedema—Docetaxel—head and neck cancer	0.0023	0.00243	CcSEcCtD
Gabapentin—Muscular weakness—Fluorouracil—head and neck cancer	0.00229	0.00242	CcSEcCtD
Gabapentin—Dysphagia—Fluorouracil—head and neck cancer	0.00224	0.00237	CcSEcCtD
Gabapentin—Sepsis—Docetaxel—head and neck cancer	0.00224	0.00237	CcSEcCtD
Gabapentin—Chills—Hydroxyurea—head and neck cancer	0.00224	0.00237	CcSEcCtD
Gabapentin—Eosinophilia—Fluorouracil—head and neck cancer	0.00222	0.00235	CcSEcCtD
Gabapentin—Ill-defined disorder—Vinblastine—head and neck cancer	0.00221	0.00234	CcSEcCtD
Gabapentin—CACNA2D1—thyroid gland—head and neck cancer	0.00221	0.0409	CbGeAlD
Gabapentin—Alopecia—Hydroxyurea—head and neck cancer	0.00221	0.00233	CcSEcCtD
Gabapentin—Anaemia—Vinblastine—head and neck cancer	0.0022	0.00233	CcSEcCtD
Gabapentin—Angina pectoris—Fluorouracil—head and neck cancer	0.00219	0.00231	CcSEcCtD
Gabapentin—Phlebitis—Docetaxel—head and neck cancer	0.00218	0.0023	CcSEcCtD
Gabapentin—Erythema—Hydroxyurea—head and neck cancer	0.00217	0.0023	CcSEcCtD
Gabapentin—Thrombophlebitis—Docetaxel—head and neck cancer	0.00217	0.00229	CcSEcCtD
Gabapentin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00216	0.00228	CcSEcCtD
Gabapentin—Malaise—Vinblastine—head and neck cancer	0.00215	0.00227	CcSEcCtD
Gabapentin—Vertigo—Vinblastine—head and neck cancer	0.00214	0.00226	CcSEcCtD
Gabapentin—Leukopenia—Vinblastine—head and neck cancer	0.00213	0.00225	CcSEcCtD
Gabapentin—ADORA1—thyroid gland—head and neck cancer	0.00213	0.0395	CbGeAlD
Gabapentin—Swelling—Docetaxel—head and neck cancer	0.00213	0.00225	CcSEcCtD
Gabapentin—Deafness—Docetaxel—head and neck cancer	0.0021	0.00222	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00209	0.00221	CcSEcCtD
Gabapentin—Hepatic failure—Docetaxel—head and neck cancer	0.00209	0.00221	CcSEcCtD
Gabapentin—BCAT1—lymph node—head and neck cancer	0.00208	0.0385	CbGeAlD
Gabapentin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00207	0.00219	CcSEcCtD
Gabapentin—Convulsion—Vinblastine—head and neck cancer	0.00206	0.00218	CcSEcCtD
Gabapentin—Hypertension—Vinblastine—head and neck cancer	0.00206	0.00217	CcSEcCtD
Gabapentin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00205	0.00217	CcSEcCtD
Gabapentin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00202	0.00213	CcSEcCtD
Gabapentin—Pneumonia—Fluorouracil—head and neck cancer	0.00201	0.00213	CcSEcCtD
Gabapentin—Anaemia—Hydroxyurea—head and neck cancer	0.00201	0.00212	CcSEcCtD
Gabapentin—Discomfort—Vinblastine—head and neck cancer	0.002	0.00212	CcSEcCtD
Gabapentin—Infestation NOS—Fluorouracil—head and neck cancer	0.002	0.00212	CcSEcCtD
Gabapentin—Infestation—Fluorouracil—head and neck cancer	0.002	0.00212	CcSEcCtD
Gabapentin—Atrial fibrillation—Docetaxel—head and neck cancer	0.00198	0.00209	CcSEcCtD
Gabapentin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00197	0.00209	CcSEcCtD
Gabapentin—Renal impairment—Docetaxel—head and neck cancer	0.00197	0.00208	CcSEcCtD
Gabapentin—Myocardial infarction—Fluorouracil—head and neck cancer	0.00196	0.00207	CcSEcCtD
Gabapentin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00196	0.00207	CcSEcCtD
Gabapentin—Dermatitis bullous—Docetaxel—head and neck cancer	0.00196	0.00207	CcSEcCtD
Gabapentin—CACNA2D1—head—head and neck cancer	0.00196	0.0363	CbGeAlD
Gabapentin—Malaise—Hydroxyurea—head and neck cancer	0.00196	0.00207	CcSEcCtD
Gabapentin—Stomatitis—Fluorouracil—head and neck cancer	0.00195	0.00206	CcSEcCtD
Gabapentin—Urinary tract infection—Fluorouracil—head and neck cancer	0.00195	0.00206	CcSEcCtD
Gabapentin—Conjunctivitis—Fluorouracil—head and neck cancer	0.00195	0.00206	CcSEcCtD
Gabapentin—Leukopenia—Hydroxyurea—head and neck cancer	0.00195	0.00206	CcSEcCtD
Gabapentin—Cardiac failure—Docetaxel—head and neck cancer	0.00192	0.00203	CcSEcCtD
Gabapentin—Lethargy—Docetaxel—head and neck cancer	0.00191	0.00202	CcSEcCtD
Gabapentin—CACNA2D2—lymph node—head and neck cancer	0.00191	0.0353	CbGeAlD
Gabapentin—Thrombocytopenia—Vinblastine—head and neck cancer	0.0019	0.00201	CcSEcCtD
Gabapentin—ADORA1—head—head and neck cancer	0.00189	0.035	CbGeAlD
Gabapentin—Epistaxis—Fluorouracil—head and neck cancer	0.00189	0.002	CcSEcCtD
Gabapentin—Convulsion—Hydroxyurea—head and neck cancer	0.00188	0.00199	CcSEcCtD
Gabapentin—Hyponatraemia—Docetaxel—head and neck cancer	0.00188	0.00199	CcSEcCtD
Gabapentin—Sinusitis—Fluorouracil—head and neck cancer	0.00188	0.00199	CcSEcCtD
Gabapentin—Pain in extremity—Docetaxel—head and neck cancer	0.00187	0.00198	CcSEcCtD
Gabapentin—Anorexia—Vinblastine—head and neck cancer	0.00185	0.00196	CcSEcCtD
Gabapentin—Migraine—Docetaxel—head and neck cancer	0.00185	0.00195	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00184	0.00194	CcSEcCtD
Gabapentin—Discomfort—Hydroxyurea—head and neck cancer	0.00183	0.00193	CcSEcCtD
Gabapentin—Rhinitis—Fluorouracil—head and neck cancer	0.0018	0.0019	CcSEcCtD
Gabapentin—Haemorrhage—Fluorouracil—head and neck cancer	0.0018	0.0019	CcSEcCtD
Gabapentin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00179	0.00189	CcSEcCtD
Gabapentin—Pharyngitis—Fluorouracil—head and neck cancer	0.00178	0.00189	CcSEcCtD
Gabapentin—Oedema—Hydroxyurea—head and neck cancer	0.00177	0.00187	CcSEcCtD
Gabapentin—Ataxia—Docetaxel—head and neck cancer	0.00176	0.00186	CcSEcCtD
Gabapentin—Infection—Hydroxyurea—head and neck cancer	0.00176	0.00186	CcSEcCtD
Gabapentin—Paraesthesia—Vinblastine—head and neck cancer	0.00175	0.00185	CcSEcCtD
Gabapentin—Dehydration—Docetaxel—head and neck cancer	0.00174	0.00184	CcSEcCtD
Gabapentin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00174	0.00184	CcSEcCtD
Gabapentin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00174	0.00184	CcSEcCtD
Gabapentin—Liver function test abnormal—Docetaxel—head and neck cancer	0.00173	0.00183	CcSEcCtD
Gabapentin—Skin disorder—Hydroxyurea—head and neck cancer	0.00172	0.00182	CcSEcCtD
Gabapentin—Dry skin—Docetaxel—head and neck cancer	0.00172	0.00182	CcSEcCtD
Gabapentin—Breast disorder—Docetaxel—head and neck cancer	0.00169	0.00179	CcSEcCtD
Gabapentin—Anorexia—Hydroxyurea—head and neck cancer	0.00169	0.00179	CcSEcCtD
Gabapentin—Decreased appetite—Vinblastine—head and neck cancer	0.00169	0.00179	CcSEcCtD
Gabapentin—Nasopharyngitis—Docetaxel—head and neck cancer	0.00168	0.00177	CcSEcCtD
Gabapentin—Constipation—Vinblastine—head and neck cancer	0.00166	0.00176	CcSEcCtD
Gabapentin—Pain—Vinblastine—head and neck cancer	0.00166	0.00176	CcSEcCtD
Gabapentin—Dysphagia—Docetaxel—head and neck cancer	0.00162	0.00171	CcSEcCtD
Gabapentin—Feeling abnormal—Vinblastine—head and neck cancer	0.0016	0.00169	CcSEcCtD
Gabapentin—Bronchospasm—Docetaxel—head and neck cancer	0.00159	0.00168	CcSEcCtD
Gabapentin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00159	0.00168	CcSEcCtD
Gabapentin—Alopecia—Fluorouracil—head and neck cancer	0.00159	0.00168	CcSEcCtD
Gabapentin—Dyspnoea—Hydroxyurea—head and neck cancer	0.00158	0.00167	CcSEcCtD
Gabapentin—Angina pectoris—Docetaxel—head and neck cancer	0.00158	0.00167	CcSEcCtD
Gabapentin—Somnolence—Hydroxyurea—head and neck cancer	0.00158	0.00167	CcSEcCtD
Gabapentin—Erythema—Fluorouracil—head and neck cancer	0.00156	0.00165	CcSEcCtD
Gabapentin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00156	0.00165	CcSEcCtD
Gabapentin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00154	0.00163	CcSEcCtD
Gabapentin—Abdominal pain—Vinblastine—head and neck cancer	0.00154	0.00163	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00153	0.00162	CcSEcCtD
Gabapentin—Fatigue—Hydroxyurea—head and neck cancer	0.00153	0.00162	CcSEcCtD
Gabapentin—Pain—Hydroxyurea—head and neck cancer	0.00152	0.0016	CcSEcCtD
Gabapentin—Constipation—Hydroxyurea—head and neck cancer	0.00152	0.0016	CcSEcCtD
Gabapentin—Weight increased—Docetaxel—head and neck cancer	0.00147	0.00156	CcSEcCtD
Gabapentin—Vision blurred—Fluorouracil—head and neck cancer	0.00147	0.00156	CcSEcCtD
Gabapentin—Weight decreased—Docetaxel—head and neck cancer	0.00147	0.00155	CcSEcCtD
Gabapentin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00146	0.00155	CcSEcCtD
Gabapentin—Pneumonia—Docetaxel—head and neck cancer	0.00145	0.00154	CcSEcCtD
Gabapentin—Anaemia—Fluorouracil—head and neck cancer	0.00145	0.00153	CcSEcCtD
Gabapentin—Infestation NOS—Docetaxel—head and neck cancer	0.00144	0.00153	CcSEcCtD
Gabapentin—Infestation—Docetaxel—head and neck cancer	0.00144	0.00153	CcSEcCtD
Gabapentin—Hypersensitivity—Vinblastine—head and neck cancer	0.00143	0.00151	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00143	0.00151	CcSEcCtD
Gabapentin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00142	0.00151	CcSEcCtD
Gabapentin—Renal failure—Docetaxel—head and neck cancer	0.00142	0.0015	CcSEcCtD
Gabapentin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00142	0.0015	CcSEcCtD
Gabapentin—Myocardial infarction—Docetaxel—head and neck cancer	0.00142	0.0015	CcSEcCtD
Gabapentin—Stomatitis—Docetaxel—head and neck cancer	0.00141	0.00149	CcSEcCtD
Gabapentin—Jaundice—Docetaxel—head and neck cancer	0.00141	0.00149	CcSEcCtD
Gabapentin—Conjunctivitis—Docetaxel—head and neck cancer	0.0014	0.00148	CcSEcCtD
Gabapentin—Body temperature increased—Hydroxyurea—head and neck cancer	0.0014	0.00148	CcSEcCtD
Gabapentin—Leukopenia—Fluorouracil—head and neck cancer	0.0014	0.00148	CcSEcCtD
Gabapentin—Asthenia—Vinblastine—head and neck cancer	0.0014	0.00148	CcSEcCtD
Gabapentin—CACNA2D1—lymph node—head and neck cancer	0.00137	0.0254	CbGeAlD
Gabapentin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00137	0.00144	CcSEcCtD
Gabapentin—Epistaxis—Docetaxel—head and neck cancer	0.00136	0.00144	CcSEcCtD
Gabapentin—Convulsion—Fluorouracil—head and neck cancer	0.00136	0.00143	CcSEcCtD
Gabapentin—Myalgia—Fluorouracil—head and neck cancer	0.00133	0.00141	CcSEcCtD
Gabapentin—Chest pain—Fluorouracil—head and neck cancer	0.00133	0.00141	CcSEcCtD
Gabapentin—Diarrhoea—Vinblastine—head and neck cancer	0.00133	0.00141	CcSEcCtD
Gabapentin—ADORA1—lymph node—head and neck cancer	0.00132	0.0245	CbGeAlD
Gabapentin—Discomfort—Fluorouracil—head and neck cancer	0.00132	0.00139	CcSEcCtD
Gabapentin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00131	0.00138	CcSEcCtD
Gabapentin—Rhinitis—Docetaxel—head and neck cancer	0.0013	0.00137	CcSEcCtD
Gabapentin—Hepatitis—Docetaxel—head and neck cancer	0.0013	0.00137	CcSEcCtD
Gabapentin—Haemorrhage—Docetaxel—head and neck cancer	0.0013	0.00137	CcSEcCtD
Gabapentin—Hypoaesthesia—Docetaxel—head and neck cancer	0.00129	0.00136	CcSEcCtD
Gabapentin—Confusional state—Fluorouracil—head and neck cancer	0.00129	0.00136	CcSEcCtD
Gabapentin—Pharyngitis—Docetaxel—head and neck cancer	0.00129	0.00136	CcSEcCtD
Gabapentin—Dizziness—Vinblastine—head and neck cancer	0.00129	0.00136	CcSEcCtD
Gabapentin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00128	0.00135	CcSEcCtD
Gabapentin—Oedema peripheral—Docetaxel—head and neck cancer	0.00128	0.00135	CcSEcCtD
Gabapentin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00128	0.00135	CcSEcCtD
Gabapentin—Oedema—Fluorouracil—head and neck cancer	0.00128	0.00135	CcSEcCtD
Gabapentin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00127	0.00135	CcSEcCtD
Gabapentin—Asthenia—Hydroxyurea—head and neck cancer	0.00127	0.00135	CcSEcCtD
Gabapentin—Urethral disorder—Docetaxel—head and neck cancer	0.00127	0.00134	CcSEcCtD
Gabapentin—Infection—Fluorouracil—head and neck cancer	0.00127	0.00134	CcSEcCtD
Gabapentin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00125	0.00132	CcSEcCtD
Gabapentin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00125	0.00132	CcSEcCtD
Gabapentin—Visual impairment—Docetaxel—head and neck cancer	0.00125	0.00132	CcSEcCtD
Gabapentin—Tachycardia—Fluorouracil—head and neck cancer	0.00125	0.00132	CcSEcCtD
Gabapentin—Vomiting—Vinblastine—head and neck cancer	0.00124	0.00131	CcSEcCtD
Gabapentin—Erythema multiforme—Docetaxel—head and neck cancer	0.00123	0.0013	CcSEcCtD
Gabapentin—Headache—Vinblastine—head and neck cancer	0.00122	0.00129	CcSEcCtD
Gabapentin—Anorexia—Fluorouracil—head and neck cancer	0.00122	0.00129	CcSEcCtD
Gabapentin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00121	0.00128	CcSEcCtD
Gabapentin—Eye disorder—Docetaxel—head and neck cancer	0.00121	0.00128	CcSEcCtD
Gabapentin—Cardiac disorder—Docetaxel—head and neck cancer	0.0012	0.00127	CcSEcCtD
Gabapentin—Hypotension—Fluorouracil—head and neck cancer	0.00119	0.00126	CcSEcCtD
Gabapentin—Dizziness—Hydroxyurea—head and neck cancer	0.00117	0.00124	CcSEcCtD
Gabapentin—Immune system disorder—Docetaxel—head and neck cancer	0.00117	0.00124	CcSEcCtD
Gabapentin—Mediastinal disorder—Docetaxel—head and neck cancer	0.00117	0.00124	CcSEcCtD
Gabapentin—Chills—Docetaxel—head and neck cancer	0.00116	0.00123	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00116	0.00123	CcSEcCtD
Gabapentin—Nausea—Vinblastine—head and neck cancer	0.00116	0.00122	CcSEcCtD
Gabapentin—Insomnia—Fluorouracil—head and neck cancer	0.00115	0.00122	CcSEcCtD
Gabapentin—Paraesthesia—Fluorouracil—head and neck cancer	0.00115	0.00121	CcSEcCtD
Gabapentin—Alopecia—Docetaxel—head and neck cancer	0.00115	0.00121	CcSEcCtD
Gabapentin—Dyspnoea—Fluorouracil—head and neck cancer	0.00114	0.0012	CcSEcCtD
Gabapentin—Mental disorder—Docetaxel—head and neck cancer	0.00114	0.0012	CcSEcCtD
Gabapentin—Somnolence—Fluorouracil—head and neck cancer	0.00113	0.0012	CcSEcCtD
Gabapentin—Malnutrition—Docetaxel—head and neck cancer	0.00113	0.00119	CcSEcCtD
Gabapentin—Erythema—Docetaxel—head and neck cancer	0.00113	0.00119	CcSEcCtD
Gabapentin—Vomiting—Hydroxyurea—head and neck cancer	0.00113	0.00119	CcSEcCtD
Gabapentin—Dyspepsia—Fluorouracil—head and neck cancer	0.00112	0.00119	CcSEcCtD
Gabapentin—Rash—Hydroxyurea—head and neck cancer	0.00112	0.00118	CcSEcCtD
Gabapentin—Dermatitis—Hydroxyurea—head and neck cancer	0.00112	0.00118	CcSEcCtD
Gabapentin—Headache—Hydroxyurea—head and neck cancer	0.00111	0.00117	CcSEcCtD
Gabapentin—Decreased appetite—Fluorouracil—head and neck cancer	0.00111	0.00117	CcSEcCtD
Gabapentin—Dysgeusia—Docetaxel—head and neck cancer	0.00111	0.00117	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0011	0.00117	CcSEcCtD
Gabapentin—Back pain—Docetaxel—head and neck cancer	0.00109	0.00115	CcSEcCtD
Gabapentin—Pain—Fluorouracil—head and neck cancer	0.00109	0.00115	CcSEcCtD
Gabapentin—Muscle spasms—Docetaxel—head and neck cancer	0.00109	0.00115	CcSEcCtD
Gabapentin—Nausea—Hydroxyurea—head and neck cancer	0.00105	0.00111	CcSEcCtD
Gabapentin—Feeling abnormal—Fluorouracil—head and neck cancer	0.00105	0.00111	CcSEcCtD
Gabapentin—Anaemia—Docetaxel—head and neck cancer	0.00104	0.0011	CcSEcCtD
Gabapentin—Urticaria—Fluorouracil—head and neck cancer	0.00101	0.00107	CcSEcCtD
Gabapentin—Syncope—Docetaxel—head and neck cancer	0.00101	0.00107	CcSEcCtD
Gabapentin—Leukopenia—Docetaxel—head and neck cancer	0.00101	0.00107	CcSEcCtD
Gabapentin—Body temperature increased—Fluorouracil—head and neck cancer	0.00101	0.00107	CcSEcCtD
Gabapentin—Palpitations—Docetaxel—head and neck cancer	0.000998	0.00105	CcSEcCtD
Gabapentin—Loss of consciousness—Docetaxel—head and neck cancer	0.000992	0.00105	CcSEcCtD
Gabapentin—Cough—Docetaxel—head and neck cancer	0.000985	0.00104	CcSEcCtD
Gabapentin—Convulsion—Docetaxel—head and neck cancer	0.000978	0.00103	CcSEcCtD
Gabapentin—Hypertension—Docetaxel—head and neck cancer	0.000975	0.00103	CcSEcCtD
Gabapentin—Arthralgia—Docetaxel—head and neck cancer	0.000961	0.00102	CcSEcCtD
Gabapentin—Chest pain—Docetaxel—head and neck cancer	0.000961	0.00102	CcSEcCtD
Gabapentin—Myalgia—Docetaxel—head and neck cancer	0.000961	0.00102	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000955	0.00101	CcSEcCtD
Gabapentin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000941	0.000994	CcSEcCtD
Gabapentin—Dry mouth—Docetaxel—head and neck cancer	0.00094	0.000994	CcSEcCtD
Gabapentin—Confusional state—Docetaxel—head and neck cancer	0.000929	0.000982	CcSEcCtD
Gabapentin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000921	0.000974	CcSEcCtD
Gabapentin—Oedema—Docetaxel—head and neck cancer	0.000921	0.000974	CcSEcCtD
Gabapentin—Infection—Docetaxel—head and neck cancer	0.000915	0.000968	CcSEcCtD
Gabapentin—Shock—Docetaxel—head and neck cancer	0.000907	0.000958	CcSEcCtD
Gabapentin—Nervous system disorder—Docetaxel—head and neck cancer	0.000904	0.000955	CcSEcCtD
Gabapentin—Pruritus—Fluorouracil—head and neck cancer	0.000903	0.000955	CcSEcCtD
Gabapentin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000902	0.000954	CcSEcCtD
Gabapentin—Tachycardia—Docetaxel—head and neck cancer	0.000899	0.000951	CcSEcCtD
Gabapentin—Skin disorder—Docetaxel—head and neck cancer	0.000895	0.000946	CcSEcCtD
Gabapentin—Anorexia—Docetaxel—head and neck cancer	0.000878	0.000928	CcSEcCtD
Gabapentin—Diarrhoea—Fluorouracil—head and neck cancer	0.000873	0.000923	CcSEcCtD
Gabapentin—Hypotension—Docetaxel—head and neck cancer	0.000861	0.00091	CcSEcCtD
Gabapentin—Dizziness—Fluorouracil—head and neck cancer	0.000844	0.000892	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000839	0.000887	CcSEcCtD
Gabapentin—Insomnia—Docetaxel—head and neck cancer	0.000833	0.000881	CcSEcCtD
Gabapentin—Paraesthesia—Docetaxel—head and neck cancer	0.000827	0.000875	CcSEcCtD
Gabapentin—Dyspnoea—Docetaxel—head and neck cancer	0.000821	0.000868	CcSEcCtD
Gabapentin—Somnolence—Docetaxel—head and neck cancer	0.000819	0.000866	CcSEcCtD
Gabapentin—Vomiting—Fluorouracil—head and neck cancer	0.000812	0.000858	CcSEcCtD
Gabapentin—Dyspepsia—Docetaxel—head and neck cancer	0.000811	0.000857	CcSEcCtD
Gabapentin—Rash—Fluorouracil—head and neck cancer	0.000805	0.000851	CcSEcCtD
Gabapentin—Dermatitis—Fluorouracil—head and neck cancer	0.000804	0.00085	CcSEcCtD
Gabapentin—Decreased appetite—Docetaxel—head and neck cancer	0.000801	0.000847	CcSEcCtD
Gabapentin—Headache—Fluorouracil—head and neck cancer	0.0008	0.000845	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000795	0.000841	CcSEcCtD
Gabapentin—Fatigue—Docetaxel—head and neck cancer	0.000794	0.00084	CcSEcCtD
Gabapentin—Pain—Docetaxel—head and neck cancer	0.000788	0.000833	CcSEcCtD
Gabapentin—Constipation—Docetaxel—head and neck cancer	0.000788	0.000833	CcSEcCtD
Gabapentin—Feeling abnormal—Docetaxel—head and neck cancer	0.000759	0.000803	CcSEcCtD
Gabapentin—Nausea—Fluorouracil—head and neck cancer	0.000758	0.000802	CcSEcCtD
Gabapentin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000753	0.000796	CcSEcCtD
Gabapentin—Body temperature increased—Docetaxel—head and neck cancer	0.000728	0.00077	CcSEcCtD
Gabapentin—Abdominal pain—Docetaxel—head and neck cancer	0.000728	0.00077	CcSEcCtD
Gabapentin—Hypersensitivity—Docetaxel—head and neck cancer	0.000679	0.000718	CcSEcCtD
Gabapentin—Asthenia—Docetaxel—head and neck cancer	0.000661	0.000699	CcSEcCtD
Gabapentin—Pruritus—Docetaxel—head and neck cancer	0.000652	0.000689	CcSEcCtD
Gabapentin—Diarrhoea—Docetaxel—head and neck cancer	0.00063	0.000666	CcSEcCtD
Gabapentin—Dizziness—Docetaxel—head and neck cancer	0.000609	0.000644	CcSEcCtD
Gabapentin—Vomiting—Docetaxel—head and neck cancer	0.000586	0.000619	CcSEcCtD
Gabapentin—Rash—Docetaxel—head and neck cancer	0.000581	0.000614	CcSEcCtD
Gabapentin—Dermatitis—Docetaxel—head and neck cancer	0.00058	0.000614	CcSEcCtD
Gabapentin—Headache—Docetaxel—head and neck cancer	0.000577	0.00061	CcSEcCtD
Gabapentin—Nausea—Docetaxel—head and neck cancer	0.000547	0.000579	CcSEcCtD
